JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for NOVAVAX · Vaccine Manufacturer

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $30,000.00 income · posted Dec 5, 2025

Lobbying activity 1

Health Issues

Issues related to vaccines

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem